Investigation of ovarian cancer associated sialylation changes in N-linked glycopeptides by quantitative proteomics

Investigation of ovarian cancer associated sialylation changes in N-linked glycopeptides by quantitative proteomics

<p>Abstract</p> <p>Background</p> <p>In approximately 80% of patients, ovarian cancer is diagnosed when the patient is already in the advanced stages of the disease. CA125 is currently used as the marker for ovarian cancer; however, it lacks specificity and sensitivity...

Full description

Bibliographic Details
Main Authors: Shetty Vivekananda, Hafner Julie, Shah Punit, Nickens Zacharie, Philip Ramila
Format: Article
Language:English
Published: BMC 2012-08-01
Series:Clinical Proteomics
Subjects:
Ovarian cancer
Quantitative proteomics
Sialylation
Lectin
N-linked glycopeptides
Mass spectrometry
Western blot
Online Access:http://www.clinicalproteomicsjournal.com/content/9/1/10

Internet

http://www.clinicalproteomicsjournal.com/content/9/1/10

Similar Items